Cite
HARVARD Citation
Marshall, J. et al. (2013). Phase I dose-escalation study of afatinib, an ErbB family blocker, plus docetaxel in patients with advanced cancer. Future oncology. pp. 271-281. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marshall, J. et al. (2013). Phase I dose-escalation study of afatinib, an ErbB family blocker, plus docetaxel in patients with advanced cancer. Future oncology. pp. 271-281. [Online].